|
FR2764292B1
(en)
*
|
1997-06-10 |
2000-12-29 |
Innothera Lab Sa |
USE OF DICETONIC TETRACYCLE DERIVATIVES, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPEUTICS
|
|
US6307047B1
(en)
|
1997-08-22 |
2001-10-23 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6525053B1
(en)
|
1997-08-22 |
2003-02-25 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
DE69816651T2
(en)
|
1997-09-05 |
2004-04-01 |
Glaxo Group Ltd., Greenford |
2,3-DIARYL-PYRAZOLO [1,5-B] PYRIDAZINE DERIVATIVES, THE PRODUCTION AND USE THEREOF AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS
|
|
FR2770131A1
(en)
*
|
1997-10-27 |
1999-04-30 |
Union Pharma Scient Appl |
Analgesic combinations of a cyclooxygenase-2 inhibitor and acetaminophen or an opiate having synergistic activity
|
|
FR2771005B1
(en)
*
|
1997-11-18 |
2002-06-07 |
Union Pharma Scient Appl |
NEW PHARMACEUTICAL ASSOCIATION WITH ANALGESIC ACTIVITY
|
|
GB9810920D0
(en)
*
|
1998-05-21 |
1998-07-22 |
Merck Sharp & Dohme |
Therapeutic use
|
|
ES2140354B1
(en)
*
|
1998-08-03 |
2000-11-01 |
S A L V A T Lab Sa |
IMIDAZO (1,2A) AZINAS SUBSTITUTED AS SELECTIVE INHIBITORS OF COX-2.
|
|
TW587079B
(en)
*
|
1998-09-25 |
2004-05-11 |
Almirall Prodesfarma Ag |
2-phenylpyran-4-one derivatives
|
|
DE69919887T2
(en)
*
|
1998-11-03 |
2005-09-15 |
Glaxo Group Ltd., Greenford |
PYRAZOLOPYRIDINE DERIVATIVE AS SELECTIVE COX-2 INHIBITORS
|
|
AU2661400A
(en)
*
|
1999-02-27 |
2000-09-21 |
Glaxo Group Limited |
Pyrazolopyridines
|
|
EP1175214B1
(en)
|
1999-12-08 |
2004-11-24 |
Pharmacia Corporation |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
|
|
GB9930358D0
(en)
|
1999-12-22 |
2000-02-09 |
Glaxo Group Ltd |
Process for the preparation of chemical compounds
|
|
IL150368A0
(en)
|
1999-12-23 |
2002-12-01 |
Nitromed Inc |
Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
|
|
GB0002312D0
(en)
*
|
2000-02-01 |
2000-03-22 |
Glaxo Group Ltd |
Medicaments
|
|
PE20011333A1
(en)
|
2000-03-16 |
2002-01-16 |
Almirall Prodesfarma Ag |
DERIVATIVES OF 2-FENYLPYRAN-4-ONA AS INHIBITORS OF CYCLOOXYGENASE 2
|
|
PE20020146A1
(en)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
OPHTHALMIC FORMULATION INCLUDING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR
|
|
NZ524252A
(en)
|
2000-07-20 |
2004-03-26 |
Lauras As |
Cox-2 inhibitors for treating HIV and AIDS
|
|
PE20020506A1
(en)
*
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS
|
|
GB0025449D0
(en)
*
|
2000-10-17 |
2000-11-29 |
Glaxo Group Ltd |
Chemical compounds
|
|
DE60112609T2
(en)
|
2000-12-15 |
2006-01-19 |
Glaxo Group Ltd., Greenford |
pyrazolopyridines
|
|
US7163940B2
(en)
|
2000-12-15 |
2007-01-16 |
Smithkline Beecham Corporation |
Pyrazolopyridinyl pyrimidine therapeutic compounds
|
|
WO2002072581A2
(en)
|
2001-03-08 |
2002-09-19 |
Smithkline Beecham Corporation |
Pyrazolopyriadine derivatives
|
|
JP4237497B2
(en)
|
2001-03-30 |
2009-03-11 |
スミスクライン ビーチャム コーポレーション |
Pyrazolopyridines, their preparation and their use as therapeutic compounds
|
|
PE20021017A1
(en)
|
2001-04-03 |
2002-11-24 |
Pharmacia Corp |
RECONSTITUABLE PARENTERAL COMPOSITION
|
|
JP4219171B2
(en)
|
2001-04-10 |
2009-02-04 |
スミスクライン ビーチャム コーポレーション |
Antiviral pyrazolopyridine compounds
|
|
US6756498B2
(en)
|
2001-04-27 |
2004-06-29 |
Smithkline Beecham Corporation |
Process for the preparation of chemical compounds
|
|
JP2004527560A
(en)
|
2001-04-27 |
2004-09-09 |
スミスクライン ビーチャム コーポレーション |
Pyrazolo [1,5-α] pyridine derivative
|
|
WO2003000689A1
(en)
|
2001-06-21 |
2003-01-03 |
Smithkline Beecham Corporation |
Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
|
|
AR038957A1
(en)
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
COMBINATION THERAPY FOR CANCER TREATMENT
|
|
WO2003031446A1
(en)
|
2001-10-05 |
2003-04-17 |
Smithkline Beecham Corporation |
Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
|
|
GB0124931D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124934D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124939D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124933D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124941D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124936D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124938D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
JP2005516916A
(en)
|
2001-12-11 |
2005-06-09 |
スミスクライン ビーチャム コーポレーション |
Pyrazolo-pyridine derivatives as anti-herpes drugs
|
|
EP2258687B1
(en)
|
2002-02-12 |
2012-12-26 |
Glaxosmithkline LLC |
Nicotinamide derivates useful as P38 inhibitors
|
|
AU2003279622A1
(en)
|
2002-06-28 |
2004-01-19 |
Nitromed, Inc. |
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1546148A1
(en)
|
2002-10-03 |
2005-06-29 |
SmithKline Beecham Corporation |
Therapeutic compounds based on pyrazolopyridine derivatives
|
|
KR20040072004A
(en)
|
2003-02-07 |
2004-08-16 |
삼성에스디아이 주식회사 |
Emitting compound for electroluminescence device and device using thereof
|
|
GB0308201D0
(en)
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308185D0
(en)
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308186D0
(en)
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
PL2266585T3
(en)
|
2003-05-07 |
2013-10-31 |
Osteologix As |
Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
|
|
GB0318814D0
(en)
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
|
WO2006041855A2
(en)
|
2004-10-04 |
2006-04-20 |
Nitromed, Inc. |
Compositions and methods using apocynin compounds and nitric oxide donors
|
|
EP1915157A4
(en)
|
2005-08-02 |
2010-09-01 |
Nicox Sa |
Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
|
|
CA2647859C
(en)
|
2006-03-29 |
2016-01-05 |
Nitromed, Inc. |
Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
|
|
MX2009004700A
(en)
|
2006-11-06 |
2009-05-15 |
Supergen Inc |
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors.
|
|
PT3409278T
(en)
|
2011-07-21 |
2020-12-18 |
Sumitomo Dainippon Pharma Oncology Inc |
Heterocyclic protein kinase inhibitors
|
|
EP3292213A1
(en)
|
2015-05-04 |
2018-03-14 |
Academisch Medisch Centrum |
Biomarkers for the detection of aspirin insensitivity
|
|
NZ778055A
(en)
|
2019-02-12 |
2025-11-28 |
Sumitomo Pharma America Inc |
Formulations comprising heterocyclic protein kinase inhibitors
|
|
CA3209491A1
(en)
|
2021-03-15 |
2022-09-22 |
Saul Yedgar |
Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease
|